Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials von Mandler, Markus, Valera, Elvira, Rockenstein, Edward, Weninger, Harald, Patrick, Christina, Adame, Anthony, Santic, Radmila, Meindl, Stefanie, Vigl, Benjamin, Smrzka, Oskar, Schneeberger, Achim, Mattner, Frank, Masliah, Eliezer

Volltext

Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management von Galabova, Gergana, Brunner, Sylvia, Winsauer, Gabriele, Juno, Claudia, Wanko, Bettina, Mairhofer, Andreas, Lührs, Petra, Schneeberger, Achim, von Bonin, Arne, Mattner, Frank, Schmidt, Walter, Staffler, Guenther

Volltext

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy von Mandler, Markus, Valera, Elvira, Rockenstein, Edward, Mante, Michael, Weninger, Harald, Patrick, Christina, Adame, Anthony, Schmidhuber, Sabine, Santic, Radmila, Schneeberger, Achim, Schmidt, Walter, Mattner, Frank, Masliah, Eliezer

Volltext

AFFITOME® technology in neurodegenerative diseases: The doubling advantage von Schneeberger, Achim, Mandler, Markus, Mattner, Frank, Schmidt, Walter

Volltext

Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines von Mandler, Markus, Santic, Radmila, Gruber, Petra, Cinar, Yeliz, Pichler, Dagmar, Funke, Susanne Aileen, Willbold, Dieter, Schneeberger, Achim, Schmidt, Walter, Mattner, Frank

Volltext

Interleukin-12 Is Essential for a Protective Th1 Response in Mice Infected with Cryptococcus neoformans von Decken, K, Köhler, G, Palmer-Lehmann, K, Wunderlin, A, Mattner, F, Magram, J, Gately, M K, Alber, G

Volltext

The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens von FRITZ, Jorg H, BRUNNER, Sylvia, BIRNSTIEL, Max L, BUSCHLE, Michael, GABAIN, Alexander V, MATTNER, Frank, ZAUNER, Wolfgang

Volltext

The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer von Mattner, Frank, Fischer, Susanne, Guckes, Stefanie, Jin, Shenchu, Kaulen, Hildegard, Schmitt, Edgar, Rüde, Erwin, Germann, Tieno

Volltext

Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies–like model von Mandler, Markus, Rockenstein, Edward, Overk, Cassia, Mante, Michael, Florio, Jazmin, Adame, Anthony, Kim, Changyoun, Santic, Radmila, Schneeberger, Achim, Mattner, Frank, Schmidhuber, Sabine, Galabova, Gergana, Spencer, Brian, Masliah, Eliezer, Rissman, Robert A.

Volltext

Development of AFFITOPE Alzheimer vaccines: Results of phase I studies with AD01 and AD02 von Mandler, Markus, Schmidt, Walter, Mattner, Frank

Volltext

P4‐249: Development of AFFITOPE Alzheimer vaccines: Results of phase I studies with AD01 and AD02 von Mandler, Markus, Schmidt, Walter, Mattner, Frank

Volltext

Inhibition of Th1 development and treatment of chronic‐relapsing experimental allergic encephalomyelitis by a non‐hypercalcemic analogue of 1,25‐dihydroxyvitamin D3 von Mattner, Frank, Smiroldo, Simona, Galbiati, Francesca, Muller, Marc, Di Lucia, Pietro, Poliani, Pietro L., Martino, Gianvito, Panina‐Bordignon, Paola, Adorini, Luciano

Volltext

Pyroglutamate-targeting Aβ AFFITOPE® vaccines reached clinical testing : Rationale and State-of-the-Art von Mandler, Markus, Santic, Radmila, Schneeberger, Achim, Schmidt, Walter, Mattner, Frank

Volltext

P2‐479: Pyroglutamate‐targeting Aβ AFFITOPE® vaccines reached clinical testing : Rationale and State‐of‐the‐Art von Mandler, Markus, Santic, Radmila, Schneeberger, Achim, Schmidt, Walter, Mattner, Frank

Volltext

Genetically resistant mice lacking interleukin‐12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response von Mattner, Frank, Magram, Jeanne, Ferrante, Jessica, Launois, Pascal, Padova, Karin Di, Behin, Reza, Gately, Maurice K., Louis, Jacques A., Alber, Gottfried

Volltext

AFFITOPE® -based vaccination against C5a alleviates disease progression in a mouse model of Alzheimer's disease von Landlinger, Christine, Oberleitner, Lisa, Gruber, Petra, Mandler, Markus, Mattner, Frank, Staffler, Guenther

Volltext

P1‐273: Development of Alzheimer AFFITOPE vaccines ‐ from concept to clinical testing von Schneeberger, Achim, Mandler, Markus, Zauner, Wolfgang, Mattner, Frank, Schmidt, Walter

Volltext

Development of Alzheimer AFFITOPE vaccines - from concept to clinical testing von Schneeberger, Achim, Mandler, Markus, Zauner, Wolfgang, Mattner, Frank, Schmidt, Walter

Volltext

Poly- l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release... von Lingnau, Karen, Egyed, Alena, Schellack, Carola, Mattner, Frank, Buschle, Michael, Schmidt, Walter

Volltext

P3‐309: Pyroglutamate modified Abeta accumulates around synapses and micro‐plaques early in the development of Alzheimer's disease von Mandler, Markus, Santic, Radmila, Kopinits, Edith, Adame, Anthony, Rockenstein, Edward, Mattner, Frank, Masliah, Eliezer

Volltext